Key facts
| Price (PPV) | 129.20 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | rivaroxaban |
| Class | Antithrombotic agents |
| ATC code | B01AF01 |
| Manufacturer | AFRIC-PHAR |
| Presentation | Boit de 10 |
| Hospital price | 80.80 MAD |
| Data collected on | 9/8/2026 |
Indications
- Prévention des thromboses en cas d'interventions orthopédiques majeures des extrémités inférieures telles que prothèse de la hanche ou du genou. - Traitement des thromboses veineuses profondes (TVP) et des embolies pulmonaires (EP) ainsi que prévention des récidives de TVP et d'embolie pulmonaire. - Prévention de l'accident vasculaire cérébral et de l'embolie systémique en présence de fibrillation auriculaire non valvulaire.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Oxarol 10 mg (BOTTU S.A.) contains the same active substance as Rexaban 10 mg (Rivaroxaban) at the same strength, but in a different pack: Boite de 5 at 49 MAD, i.e. 9.80 MAD per unit against 12.92 MAD for Rexaban 10 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Oxarol 10 mg | BOTTU S.A. | Boite de 5 | 49 MAD | 9.80 / unit |
| Rivalto 10 mg | PHARMIS | Boite de 5 | 49 MAD | 9.80 / unit |
| Rexaban 10 mg | AFRIC-PHAR | Boite de 5 | 70 MAD | 14 / unit |
| Oxarol 10 mg | BOTTU S.A. | Boite de 10 | 90.40 MAD | 9.04 / unit |
| Valterio 10 mg | SOTHEMA | Boite de 10 | 90.40 MAD | 9.04 / unit |
| Xarelto 10 mg | BAYER S.A | Boîte de 10 | 140.50 MAD | 14.05 / unit |
| Rivalto 10 mg | PHARMIS | Boite de 35 | 298 MAD | 8.51 / unit |
| Rexaban 10 mg | AFRIC-PHAR | Boite de 35 | 386 MAD | 11.03 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Rexaban 10 mg
Rexaban 10 mg belongs to the antithrombotic agents therapeutic class. In Morocco, this drug is marketed by AFRIC-PHAR and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Rexaban 10 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Rexaban 10 mg
Answers to common questions from Moroccan patients about this drug.